NASDAQ:PTCT | Free Cash Flow | PTC THERAPEUTICS, INC.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2011-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$59.04M$1.2M-$60.24M
2025-12-31-$34.27M$2.37M-$36.65M
2025-03-31$870.1M$1.72M$868.38M100.21%
2024-12-31-$30M$3.77M-$33.77M
2024-03-31$70.76M$9.59M$61.17M
2023-12-31-$100.29M$5.57M-$105.85M
2023-03-31-$29.49M$10.27M-$39.76M
2022-12-31-$165.96M$8.62M-$174.59M
2022-03-31-$97.4M$9.31M-$106.72M
2021-12-31-$68.84M$8.73M-$77.57M
2021-03-31-$100.16M$5.67M-$105.83M
2020-12-31-$64.37M$6.35M-$70.72M
2020-03-31-$81.55M$6.02M-$87.58M
2019-12-31-$10.21M$4.65M-$14.86M
2019-03-31-$42.41M$2.87M-$45.27M
2018-12-31-$15.14M$4.61M-$19.75M
2018-03-31-$15.88M$479,000.00-$16.36M
2017-12-31$21.29M$2.04M$19.25M1515.35%
2017-03-31-$28.9M$225,000.00-$29.13M
2016-12-31-$13.32M$1.24M-$14.56M
2016-03-31-$41.59M$265,000.00-$41.85M
2015-12-31-$30.33M$956,000.00-$31.29M
2015-03-31-$36.43M$883,000.00-$37.31M
2014-12-31-$7.99M$3.51M-$11.5M
2014-03-31-$13.44M$186,000.00-$13.62M
2013-12-31-$14.46M$372,000.00-$14.84M
2013-03-31-$7.85M$21,000.00-$7.87M
2012-12-31-$11.04M$5,489.00-$11.04M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31$711.2M$8.86M$702.34M102.88%
2024-12-31-$107.69M$6.5M-$114.19M
2023-12-31-$158.42M$28.44M-$186.86M
2022-12-31-$356.65M$32.02M-$388.67M
2021-12-31-$251.33M$28.21M-$279.55M
2020-12-31-$194.07M$17.84M-$211.91M
2019-12-31-$98.64M$13.76M-$112.4M
2018-12-31-$27.64M$7.1M-$34.74M
2017-12-31-$10.06M$3.1M-$13.16M
2016-12-31-$103.57M$1.78M-$105.34M
2015-12-31-$124.34M$2.72M-$127.06M
2014-12-31-$57.27M$4.66M-$61.94M
2013-12-31-$46.92M$846,000.00-$47.77M
2012-12-31-$47.93M$189,000.00-$48.12M
2011-12-31-$20.77M$165,116.00-$20.93M-67.73%